Paula Loredo Siminovich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Paula Loredo Siminovich has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Carlos Eduardo Gasparetto3 shared publications
- Maria Renita Burg
Department of Nursing, Lutheran University of Brazil, Ulbra Canoas, Canoas-RS, Brazil
2 shared publications - Miria Elisabete Bairros de Camargo
Department of Nursing, Lutheran University of Brazil, Ulbra Canoas, Canoas-RS, Brazil
2 shared publications - Paulo Roberto Cardoso Consoni
Universidade Luterana do Brasil (ULBRA), Canoas, RS
2 shared publications - Andrea Greco
Pediatric Arrhythmias, Genetic Cardiology and Sudden Death, Institut de Recerca Sant Joan de Déu (IRSJD), Barcelona, Spain
1 shared publication - Carlos Eduardo Gasparetto
Universidade Luterana do Brasil-ULBRA Canoas RS Brasil
1 shared publication
Latest Publications
- Open Access
- 14 March 2025
- Published by MDPI AG in Cardiogenetics
- Vol. 15 (1) , 9
Brugada Syndrome and GPD1L: Definite Genotype-Phenotype Association?
The GPD1L gene encodes a small cytoplasmic protein that is involved in the regulation of sodium currents. Alterations in this gene have been associated with Brugada syndrome. This rare arrhythmogenic syndrome is characterized by a typical electrocardiographic pattern, incomplete penetrance, variable expressivity, and risk of sudden cardiac death. To date, few families with a clinical diagnosis of Brugada syndrome caused by a rare alteration in the GPD1L gene have been reported worldwide. The increase in data focused on genetic variants allows us to improve the interpretation of their role in Brugada syndrome. In our study, we have compiled the GPD1L variants reported so far in patients with a definitive clinical diagnosis or suspected Brugada syndrome. We performed an exhaustive update and interpretation of each variant following the guidelines of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Our results showed that none of the variants described to date can be classified as truly harmful in Brugada syndrome. Despite this fact, more clinical and genetic data are needed to definitively rule out the GPD1L gene as a cause of Brugada syndrome. In summary, to date, there is insufficient evidence to conclude a definitive association between GPD1L and Brugada syndrome.
- 14 March 2025
- Published by MDPI AG in Cardiogenetics
- Vol. 15 (1) , 9
Open AccessBrugada Syndrome and GPD1L: Definite Genotype-Phenotype Association?
The GPD1L gene encodes a small cytoplasmic protein that is involved in the regulation of sodium currents. Alterations in this gene have been associated with Brugada syndrome. This rare arrhythmogenic syndrome is characterized by a typical electrocardiographic pattern, incomplete penetrance, variable expressivity, and risk of sudden cardiac death. To date, few families with a clinical diagnosis of Brugada syndrome caused by a rare alteration in the GPD1L gene have been reported worldwide. The increase in data focused on genetic variants allows us to improve the interpretation of their role in Brugada syndrome. In our study, we have compiled the GPD1L variants reported so far in patients with a definitive clinical diagnosis or suspected Brugada syndrome. We performed an exhaustive update and interpretation of each variant following the guidelines of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Our results showed that none of the variants described to date can be classified as truly harmful in Brugada syndrome. Despite this fact, more clinical and genetic data are needed to definitively rule out the GPD1L gene as a cause of Brugada syndrome. In summary, to date, there is insufficient evidence to conclude a definitive association between GPD1L and Brugada syndrome.
- 12 November 2024
- Published by EDIPUCRS
- p. 353-372
A catarata e o seu cuidado na população idosa
A visão é responsável, naturalmente, por 85% das informações processadas no cérebro, e as deficiências visuais não estão distribuídas equilibradamente entre os grupos etários. Mais de 82% de todas as pessoas cegas no mundo são maiores de 50 anos, apesar de esse grupo representar apenas 19% da população mundial (Brasil, 2022).
- 12 November 2024
- Published by EDIPUCRS
- p. 353-372
A catarata e o seu cuidado na população idosa
A visão é responsável, naturalmente, por 85% das informações processadas no cérebro, e as deficiências visuais não estão distribuídas equilibradamente entre os grupos etários. Mais de 82% de todas as pessoas cegas no mundo são maiores de 50 anos, apesar de esse grupo representar apenas 19% da população mundial (Brasil, 2022).
- 12 November 2024
- Published by EDIPUCRS
- p. 211-228
Cadastros dos domicílios pela equipe de estratégia de saúde da família da população idosa
A atenção à saúde da população idosa tem como porta de entrada preferencialmente a Atenção Primária à Saúde (APS). A APS constitui o primeiro contato de indivíduos, famílias e comunidades com o Sistema Único de Saúde, trazendo os serviços de saúde o mais próximo possível aos lugares de vida e trabalho das pessoas, e significa, na Rede de Atenção à Saúde, o primeiro elemento de um processo contínuo de atenção (SBIBAE, 2019).
- 12 November 2024
- Published by EDIPUCRS
- p. 211-228
Cadastros dos domicílios pela equipe de estratégia de saúde da família da população idosa
A atenção à saúde da população idosa tem como porta de entrada preferencialmente a Atenção Primária à Saúde (APS). A APS constitui o primeiro contato de indivíduos, famílias e comunidades com o Sistema Único de Saúde, trazendo os serviços de saúde o mais próximo possível aos lugares de vida e trabalho das pessoas, e significa, na Rede de Atenção à Saúde, o primeiro elemento de um processo contínuo de atenção (SBIBAE, 2019).
- 30 July 2023
- Published by Editora Pasteur
- p. 146-156
DOENÇA INFLAMATÓRIA PÉLVICA: A IMPORTÂNCIA DO DIAGNÓSTICO PRECOCE
- 30 July 2023
- Published by Editora Pasteur
- p. 146-156
DOENÇA INFLAMATÓRIA PÉLVICA: A IMPORTÂNCIA DO DIAGNÓSTICO PRECOCE
- Open Access
- 21 July 2023
- Published by Seven Events
Hospitalization for COVID-19 in the municipality of Canoas/RS: Delineation of the population profile
Introduction: The COVID-19 pandemic started in March 2020 and is marked by a high number of infected. The symptoms of the disease are variable and the most severe cases occurred mainly in elderly patients and those with previous comorbidities. Objectives: To profile infected patients in the city of Canoas/RS, who required hospitalization for COVID-19; whose hospital discharge happened in January 2021. Method: This is a descriptive, exploratory, retrospective and documentary study, with a quantitative approach, where 51 medical records of patients living in Canoas/RS were analyzed, and had the hospital discharge in January 2021 with a positive diagnosis for the COVID-19 virus, at the city´s benchmark hospital. Results: The profile that was found: male, with an average age of 55,6 years old, white and single. The average hospitalization was 6,8 days. About the medications, the most frequently used was dexamethasone and, among other care prescribed after hospital discharge, the most known was the follow-up at the Basic Health Unit. Approximately 34 patients had some comorbidity and, also, more than half had previously used continuous medications. Only three patients in the study responded affirmatively about exposure to COVID-19 and the main symptoms presented by patients in general were dyspnea, cough and fever. Final considerations: The study shows that patients with advanced age and with chronic diseases are at greater risk of developing the severe form of COVID-19. The high rate of transmissibility can be observed by the absence of information regarding the natural history of the disease. DOI:https://doi.org/10.56238/Connexpemultidisdevolpfut-035
- 21 July 2023
- Published by Seven Events
Open AccessHospitalization for COVID-19 in the municipality of Canoas/RS: Delineation of the population profile
Introduction: The COVID-19 pandemic started in March 2020 and is marked by a high number of infected. The symptoms of the disease are variable and the most severe cases occurred mainly in elderly patients and those with previous comorbidities. Objectives: To profile infected patients in the city of Canoas/RS, who required hospitalization for COVID-19; whose hospital discharge happened in January 2021. Method: This is a descriptive, exploratory, retrospective and documentary study, with a quantitative approach, where 51 medical records of patients living in Canoas/RS were analyzed, and had the hospital discharge in January 2021 with a positive diagnosis for the COVID-19 virus, at the city´s benchmark hospital. Results: The profile that was found: male, with an average age of 55,6 years old, white and single. The average hospitalization was 6,8 days. About the medications, the most frequently used was dexamethasone and, among other care prescribed after hospital discharge, the most known was the follow-up at the Basic Health Unit. Approximately 34 patients had some comorbidity and, also, more than half had previously used continuous medications. Only three patients in the study responded affirmatively about exposure to COVID-19 and the main symptoms presented by patients in general were dyspnea, cough and fever. Final considerations: The study shows that patients with advanced age and with chronic diseases are at greater risk of developing the severe form of COVID-19. The high rate of transmissibility can be observed by the absence of information regarding the natural history of the disease. DOI:https://doi.org/10.56238/Connexpemultidisdevolpfut-035
- 1 June 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 3 (1)
Restrictive Cardiomyopathies: What’s New on the War Front?
A rare – or not so rare – condition? Restrictive cardiomyopathies, caused by primary pathologies of the heart muscle, are considered rare diseases, corresponding to about 5% of all cardiomyopathies. The most frequent form of restrictive cardiomyopathy is cardiac amyloidosis (CA), which can be considered a benchmark since, with the availability of diagnostic technologies, its detection has been made much more frequent, associated with the fact that there are effective treatment possibilities. […] Restrictive Cardiomyopathies: What’s New on the War [...] A rare – or not so rare – condition? Restrictive cardiomyopathies, caused by primary pathologies of the heart muscle, are considered rare diseases, corresponding to about 5% of all cardiomyopathies. The most frequent form of restrictive cardiomyopathy is cardiac amyloidosis (CA), which can be considered a benchmark since, with the availability of diagnostic technologies, its detection has been made much more frequent, associated with the fact that there are effective treatment possibilities. […] Restrictive Cardiomyopathies: What’s New on the War
- 1 June 2023
- Published by Sociedade Brasileira de Cardiologia in ABC Heart Failure & Cardiomyopathy
- Vol. 3 (1)
Restrictive Cardiomyopathies: What’s New on the War Front?
A rare – or not so rare – condition? Restrictive cardiomyopathies, caused by primary pathologies of the heart muscle, are considered rare diseases, corresponding to about 5% of all cardiomyopathies. The most frequent form of restrictive cardiomyopathy is cardiac amyloidosis (CA), which can be considered a benchmark since, with the availability of diagnostic technologies, its detection has been made much more frequent, associated with the fact that there are effective treatment possibilities. […] Restrictive Cardiomyopathies: What’s New on the War [...] A rare – or not so rare – condition? Restrictive cardiomyopathies, caused by primary pathologies of the heart muscle, are considered rare diseases, corresponding to about 5% of all cardiomyopathies. The most frequent form of restrictive cardiomyopathy is cardiac amyloidosis (CA), which can be considered a benchmark since, with the availability of diagnostic technologies, its detection has been made much more frequent, associated with the fact that there are effective treatment possibilities. […] Restrictive Cardiomyopathies: What’s New on the War